Skip to main content
Erschienen in: Infection 6/2017

29.05.2017 | Original Paper

Clinical characteristics and outcomes of septic bursitis

verfasst von: Sarah B. Lieber, Mary Louise Fowler, Clara Zhu, Andrew Moore, Robert H. Shmerling, Ziv Paz

Erschienen in: Infection | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Limited data guide practice in evaluation and treatment of septic bursitis. We aimed to characterize clinical characteristics, microbiology, and outcomes of patients with septic bursitis stratified by bursal involvement, presence of trauma, and management type.

Methods

We conducted a retrospective cohort study of adult patients admitted to a single center from 1998 to 2015 with culture-proven olecranon and patellar septic bursitis. Baseline characteristics, clinical features, microbial profiles, operative interventions, hospitalization lengths, and 60-day readmission rates were determined. Patients were stratified by bursitis site, presence or absence of trauma, and operative or non-operative management.

Results

Of 44 cases of septic bursitis, patients with olecranon and patellar bursitis were similar with respect to age, male predominance, and frequency of bursal trauma; patients managed operatively were younger (p = 0.05). Clinical features at presentation and comorbidities were similar despite bursitis site, history of trauma, or management. The most common organism isolated from bursal fluid was Staphylococcus aureus. Patients managed operatively were discharged to rehabilitation less frequently (p = 0.04).

Conclusions

This study of septic bursitis is among the largest reported. We were unable to identify presenting clinical features that differentiated patients treated surgically from those treated conservatively. There was no clear relationship between preceding trauma or bursitis site and clinical course, management, or outcomes. Patients with bursitis treated surgically were younger. Additional study is needed to identify patients who would benefit from early surgical intervention for septic bursitis.
Literatur
1.
Zurück zum Zitat Laupland KB, Davis HD. Olecranon septic bursitis managed in an ambulatory setting. The Calgary Home Parenteral Therapy Program Study Group. Clin Invest Med. 2001;24:171–8.PubMed Laupland KB, Davis HD. Olecranon septic bursitis managed in an ambulatory setting. The Calgary Home Parenteral Therapy Program Study Group. Clin Invest Med. 2001;24:171–8.PubMed
2.
Zurück zum Zitat Martinez-Taboada VM, et al. Cloxacillin-based therapy in severe septic bursitis: retrospective study of 82 cases. Joint Bone Spine. 2009;76:665–9.CrossRefPubMed Martinez-Taboada VM, et al. Cloxacillin-based therapy in severe septic bursitis: retrospective study of 82 cases. Joint Bone Spine. 2009;76:665–9.CrossRefPubMed
3.
Zurück zum Zitat Perez C, et al. Infectious olecranon and patellar bursitis: short-course adjuvant antibiotic therapy is not a risk factor for recurrence in adult hospitalized patients. J Antimicrob Chemother. 2010;65:1008–14.CrossRefPubMed Perez C, et al. Infectious olecranon and patellar bursitis: short-course adjuvant antibiotic therapy is not a risk factor for recurrence in adult hospitalized patients. J Antimicrob Chemother. 2010;65:1008–14.CrossRefPubMed
4.
Zurück zum Zitat Hoffmeyer P, et al. Septic olecranon bursitis in a general hospital population. Can Med Assoc J. 1980;122:874–6.PubMedPubMedCentral Hoffmeyer P, et al. Septic olecranon bursitis in a general hospital population. Can Med Assoc J. 1980;122:874–6.PubMedPubMedCentral
5.
Zurück zum Zitat Garcia-Porrua C, et al. The clinical spectrum of severe septic bursitis in Northwestern Spain: a 10 year study. J Rheumatol. 1999;26:663–7.PubMed Garcia-Porrua C, et al. The clinical spectrum of severe septic bursitis in Northwestern Spain: a 10 year study. J Rheumatol. 1999;26:663–7.PubMed
6.
Zurück zum Zitat Ho G, et al. Septic bursitis in the prepatellar and olecranon bursae. An analysis of 25 cases. Ann Intern Med. 1978;89:21–7.CrossRefPubMed Ho G, et al. Septic bursitis in the prepatellar and olecranon bursae. An analysis of 25 cases. Ann Intern Med. 1978;89:21–7.CrossRefPubMed
7.
Zurück zum Zitat Sayegh ET, Strauch RJ. Treatment of olecranon bursitis: a systematic review. Arch Orthop Trauma Surg. 2014;134:1517–36.CrossRefPubMed Sayegh ET, Strauch RJ. Treatment of olecranon bursitis: a systematic review. Arch Orthop Trauma Surg. 2014;134:1517–36.CrossRefPubMed
8.
Zurück zum Zitat Cea-Pereiro JC, et al. A comparison between septic bursitis caused by S. aureus and those caused by other organisms. Clin Rheumatol. 2001;20:10–4.CrossRefPubMed Cea-Pereiro JC, et al. A comparison between septic bursitis caused by S. aureus and those caused by other organisms. Clin Rheumatol. 2001;20:10–4.CrossRefPubMed
10.
Zurück zum Zitat Canoso JJ, Sheckman PR. Septic subcutaneous bursitis. Report of sixteen cases. J Rheumatol. 1979;6:96–102.PubMed Canoso JJ, Sheckman PR. Septic subcutaneous bursitis. Report of sixteen cases. J Rheumatol. 1979;6:96–102.PubMed
11.
Zurück zum Zitat Soderquist B, Hedstrom SA. Predisposing factors, bacteriology and antibiotic therapy in 35 cases of septic bursitis. Scand J Infect Dis. 1986;18:305–11.CrossRefPubMed Soderquist B, Hedstrom SA. Predisposing factors, bacteriology and antibiotic therapy in 35 cases of septic bursitis. Scand J Infect Dis. 1986;18:305–11.CrossRefPubMed
12.
Zurück zum Zitat Pien FD, et al. Septic bursitis: experience in a community practice. Orthopedics. 1991;14:981–4.PubMed Pien FD, et al. Septic bursitis: experience in a community practice. Orthopedics. 1991;14:981–4.PubMed
13.
Zurück zum Zitat Gomez-Rodriguez N, et al. Infectious bursitis: study of 40 cases in the prepatellar and olecranon regions. Enferm Infecc Microbiol Clin. 1997;15:237–42.PubMed Gomez-Rodriguez N, et al. Infectious bursitis: study of 40 cases in the prepatellar and olecranon regions. Enferm Infecc Microbiol Clin. 1997;15:237–42.PubMed
14.
Zurück zum Zitat Raddatz DA, et al. Septic bursitis: presentation, treatment, and prognosis. J Rheumatol. 1987;14:1160–3.PubMed Raddatz DA, et al. Septic bursitis: presentation, treatment, and prognosis. J Rheumatol. 1987;14:1160–3.PubMed
16.
Zurück zum Zitat De Angelis G, et al. Prosthetic joint infections in the elderly. Infection. 2015;43:629–37.CrossRefPubMed De Angelis G, et al. Prosthetic joint infections in the elderly. Infection. 2015;43:629–37.CrossRefPubMed
17.
Zurück zum Zitat Osmon DR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:e1–25.CrossRefPubMed Osmon DR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:e1–25.CrossRefPubMed
18.
Zurück zum Zitat Roschmann RA, Bell CL. Septic bursitis in immunocompromised patients. Am J Med. 1987;83:661–5.CrossRefPubMed Roschmann RA, Bell CL. Septic bursitis in immunocompromised patients. Am J Med. 1987;83:661–5.CrossRefPubMed
Metadaten
Titel
Clinical characteristics and outcomes of septic bursitis
verfasst von
Sarah B. Lieber
Mary Louise Fowler
Clara Zhu
Andrew Moore
Robert H. Shmerling
Ziv Paz
Publikationsdatum
29.05.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 6/2017
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-1030-3

Weitere Artikel der Ausgabe 6/2017

Infection 6/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.